Guilin Sanjin Of China Trades Well In IPO Try, First In China In 10 Months
This article was originally published in PharmAsia News
Executive Summary
China's Guilin Sanjin Pharmaceutical prompted such a response on the day of its initial public offering, the Shenzhen Stock Exchange suspended trading on the shares. Before the halt, the first trading in China since IPOs were suspended 10 months ago, Guilin Sanjin shares rose by 20 percent. Trading was suspended in the Guilin Sanjin IPO and another company for just 30 minutes under stock exchange rules. (Click here for more